322 related articles for article (PubMed ID: 31751337)
1. Vaccination strategies to control Ebola epidemics in the context of variable household inaccessibility levels.
Chowell G; Tariq A; Kiskowski M
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007814. PubMed ID: 31751337
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease.
Kucharski AJ; Eggo RM; Watson CH; Camacho A; Funk S; Edmunds WJ
Emerg Infect Dis; 2016 Jan; 22(1):105-8. PubMed ID: 26691346
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis.
Ajelli M; Merler S; Fumanelli L; Pastore Y Piontti A; Dean NE; Longini IM; Halloran ME; Vespignani A
BMC Med; 2016 Sep; 14(1):130. PubMed ID: 27600737
[TBL] [Abstract][Full Text] [Related]
4. Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control.
Coltart CE; Johnson AM; Whitty CJ
BMC Med; 2015 Oct; 13():271. PubMed ID: 26482396
[TBL] [Abstract][Full Text] [Related]
5. Containing Ebola at the Source with Ring Vaccination.
Merler S; Ajelli M; Fumanelli L; Parlamento S; Pastore Y Piontti A; Dean NE; Putoto G; Carraro D; Longini IM; Halloran ME; Vespignani A
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005093. PubMed ID: 27806049
[TBL] [Abstract][Full Text] [Related]
6. PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.
Bolay FK; Grandits G; Lane HC; Kennedy SB; Johnson MP; Fallah MP; Wilson B; Njoh WS; McNay LA; Hensley LE; Higgs ES
J Infect Dis; 2019 Apr; 219(10):1634-1641. PubMed ID: 30561672
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA
Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676
[TBL] [Abstract][Full Text] [Related]
8. Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study.
Bisanzio D; Davis AE; Talbird SE; Van Effelterre T; Metz L; Gaudig M; Mathieu VO; Brogan AJ
Vaccine; 2023 Jan; 41(3):684-693. PubMed ID: 36526505
[TBL] [Abstract][Full Text] [Related]
9. Ebola Virus: Pathogenesis and Countermeasure Development.
Furuyama W; Marzi A
Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
[TBL] [Abstract][Full Text] [Related]
10. Considerations for use of Ebola vaccine during an emergency response.
Walldorf JA; Cloessner EA; Hyde TB; MacNeil A;
Vaccine; 2019 Nov; 37(48):7190-7200. PubMed ID: 28890191
[TBL] [Abstract][Full Text] [Related]
11. Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey.
Irwin KL; Jalloh MF; Corker J; Alpha Mahmoud B; Robinson SJ; Li W; James NE; Sellu M; Jalloh MB; Diallo AA; Tracy L; Hajjeh R; VanSteelandt A; Bunnell R; Martel L; Raghunathan PL; Marston B;
Vaccine; 2017 Dec; 35(49 Pt B):6915-6923. PubMed ID: 28716555
[TBL] [Abstract][Full Text] [Related]
12. The 2014 Ebola virus disease outbreak in Pujehun, Sierra Leone: epidemiology and impact of interventions.
Ajelli M; Parlamento S; Bome D; Kebbi A; Atzori A; Frasson C; Putoto G; Carraro D; Merler S
BMC Med; 2015 Nov; 13():281. PubMed ID: 26607790
[TBL] [Abstract][Full Text] [Related]
13. Harnessing case isolation and ring vaccination to control Ebola.
Wells C; Yamin D; Ndeffo-Mbah ML; Wenzel N; Gaffney SG; Townsend JP; Meyers LA; Fallah M; Nyenswah TG; Altice FL; Atkins KE; Galvani AP
PLoS Negl Trop Dis; 2015 May; 9(5):e0003794. PubMed ID: 26024528
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against Ebola virus.
Venkatraman N; Silman D; Folegatti PM; Hill AVS
Vaccine; 2018 Aug; 36(36):5454-5459. PubMed ID: 28780120
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Coller BG; Blue J; Das R; Dubey S; Finelli L; Gupta S; Helmond F; Grant-Klein RJ; Liu K; Simon J; Troth S; VanRheenen S; Waterbury J; Wivel A; Wolf J; Heppner DG; Kemp T; Nichols R; Monath TP
Vaccine; 2017 Aug; 35(35 Pt A):4465-4469. PubMed ID: 28647166
[TBL] [Abstract][Full Text] [Related]
16. Evaluating Subcriticality during the Ebola Epidemic in West Africa.
Enanoria WT; Worden L; Liu F; Gao D; Ackley S; Scott J; Deiner M; Mwebaze E; Ip W; Lietman TM; Porco TC
PLoS One; 2015; 10(10):e0140651. PubMed ID: 26484544
[TBL] [Abstract][Full Text] [Related]
17. Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.
Higgs ES; Dubey SA; Coller BAG; Simon JK; Bollinger L; Sorenson RA; Wilson B; Nason MC; Hensley LE
Curr Top Microbiol Immunol; 2017; 411():229-261. PubMed ID: 28918539
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-vectored Ebola vaccines.
Gilbert SC
Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
[TBL] [Abstract][Full Text] [Related]
19. The potential impact of a prophylactic vaccine for Ebola in Sierra Leone.
Bodine EN; Cook C; Shorten M
Math Biosci Eng; 2018 Apr; 15(2):337-359. PubMed ID: 29161839
[TBL] [Abstract][Full Text] [Related]
20. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
